Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

在多发性骨髓瘤中，初始自体/减低强度异基因联合移植可降低复发率，但仅能略微延长无进展生存期，而不能延长总生存期。